iVascular
Jan Van Overbeke is an experienced professional in the medical device industry, currently serving as the Country Manager for iVascular in Belgium and Luxembourg since March 2016. In this role, Jan is responsible for strategic consulting, including developing business plans and sales strategies, and implementing iVascular's portfolio in the peripheral and interventional cardiology market. Additionally, Jan manages Javanom as General Manager, focusing on KOL management, sales management, marketing, and operations. Previously, Jan held positions such as Sales Manager at .be medical, where responsibilities included launching new projects and products, as well as extensive roles at Abbott SA NV spanning 17 years, culminating in the position of Sales and Marketing Manager for Endovascular Solutions. Jan's early career included roles in sales and nursing, contributing to a strong foundation in healthcare. Educational qualifications include studies at Vlecko Brussel and training at Sint Franciscusschool voor verpleging.
This person is not in any offices
iVascular
1 followers
The purpose of iVascular is to develop innovative advanced medical devices and therapies for the treatment of disorders of the cardiovascular system. Its staff has extensive knowledge of biopolymers, coatings, drug delivery, mechanical engineering, medicine and pharmacy. They bring together recognised experience in the development of medical devices and implants. Thanks to the know-how provided by our scientists and technicians and an appropriate investment in technology, iVascular has implemented a vertical integration project allowing it to develop, innovate and produce cardiovascular devices from basic raw materials (plastics, polymers, metals, etc.) to the final device or implant. iVascular possesses and develops its own technologies, which have made possible the vertical integration of each and every one of the processes involved in developing a device, from the earliest design stages through to final production. In this way we guarantee the highest quality standards in all our products. iVascular has a technology center with more than 1000 m² of clean rooms (ISO 7 and ISO 8) and 250 m² of R&D laboratories equipped with the most comprehensive, advanced instrumentation in the biotechnology field. Through its direct and indirect sales network, iVascular is present in more than 70 countries around the world, and is providing with full range of products for interventional cardiology and endovascular procedures. For more information about iVascular, please, visit www.ivascular.global or If you have any questions or comments, we are ready to help you out by an e-mail to info@ivascular.global